Targeting endothelial thioredoxin-interacting protein (TXNIP) protects from metabolic disorder-related impairment of vascular function and post-ischemic revascularisation

Introduction Although thioredoxin-interacting protein (TXNIP) is involved in a variety of biological functions, the contribution of endothelial TXNIP has not been well-defined in regards to endothelial and vascular function or in post-ischemic revascularisation. We postulated that inhibition of endo...

Full description

Saved in:
Bibliographic Details
Published inAngiogenesis (London) Vol. 23; no. 2; pp. 249 - 264
Main Authors Domingues, Alison, Boisson-Vidal, Catherine, Marquet de Rouge, Perrine, Dizier, Blandine, Sadoine, Jérémy, Mignon, Virginie, Vessières, Emilie, Henrion, Daniel, Escriou, Virginie, Bigey, Pascal, Chaussain, Catherine, Smadja, David M., Nivet-Antoine, Valérie
Format Journal Article
LanguageEnglish
Published Dordrecht Springer Netherlands 01.05.2020
Springer Nature B.V
Springer Verlag
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Introduction Although thioredoxin-interacting protein (TXNIP) is involved in a variety of biological functions, the contribution of endothelial TXNIP has not been well-defined in regards to endothelial and vascular function or in post-ischemic revascularisation. We postulated that inhibition of endothelial TXNIP with siRNA or in a Cre-LoxP system could be involved in protection from high fat, high protein, low carbohydrate (HFHPLC) diet-induced oxidative stress and endothelial dysfunction, leading to vascular damage and impaired revascularisation in vivo. Methods and results To investigate the role of endothelial TXNIP, the TXNIP gene was deleted in endothelial cells using anti-TXNIP siRNA treatment or the Cre-LoxP system. Murine models were fed a HFHPLC diet, known to induce metabolic disorders. Endothelial TXNIP targeting resulted in protection against metabolic disorder-related endothelial oxidative stress and endothelial dysfunction. This protective effect mitigates media cell loss induced by metabolic disorders and hampered metabolic disorder-related vascular dysfunction assessed by aortic reactivity and distensibility. In aortic ring cultures, metabolic disorders impaired vessel sprouting and this alteration was alleviated by deletion of endothelial TXNIP. When subjected to ischemia, mice fed a HFHPLC diet exhibited defective post-ischemic angiogenesis and impaired blood flow recovery in hind limb ischemia. However, reducing endothelial TXNIP rescued metabolic disorder-related impairment of ischemia-induced revascularisation. Conclusion Collectively, these results show that targeting endothelial TXNIP in metabolic disorders is essential to maintaining endothelial function, vascular function and improving ischemia-induced revascularisation, making TXNIP a potential therapeutic target for therapy of vascular complications related to metabolic disorders.
AbstractList Although thioredoxin-interacting protein (TXNIP) is involved in a variety of biological functions, the contribution of endothelial TXNIP has not been well-defined in regards to endothelial and vascular function or in post-ischemic revascularisation. We postulated that inhibition of endothelial TXNIP with siRNA or in a Cre-LoxP system could be involved in protection from high fat, high protein, low carbohydrate (HFHPLC) diet-induced oxidative stress and endothelial dysfunction, leading to vascular damage and impaired revascularisation in vivo.INTRODUCTIONAlthough thioredoxin-interacting protein (TXNIP) is involved in a variety of biological functions, the contribution of endothelial TXNIP has not been well-defined in regards to endothelial and vascular function or in post-ischemic revascularisation. We postulated that inhibition of endothelial TXNIP with siRNA or in a Cre-LoxP system could be involved in protection from high fat, high protein, low carbohydrate (HFHPLC) diet-induced oxidative stress and endothelial dysfunction, leading to vascular damage and impaired revascularisation in vivo.To investigate the role of endothelial TXNIP, the TXNIP gene was deleted in endothelial cells using anti-TXNIP siRNA treatment or the Cre-LoxP system. Murine models were fed a HFHPLC diet, known to induce metabolic disorders. Endothelial TXNIP targeting resulted in protection against metabolic disorder-related endothelial oxidative stress and endothelial dysfunction. This protective effect mitigates media cell loss induced by metabolic disorders and hampered metabolic disorder-related vascular dysfunction assessed by aortic reactivity and distensibility. In aortic ring cultures, metabolic disorders impaired vessel sprouting and this alteration was alleviated by deletion of endothelial TXNIP. When subjected to ischemia, mice fed a HFHPLC diet exhibited defective post-ischemic angiogenesis and impaired blood flow recovery in hind limb ischemia. However, reducing endothelial TXNIP rescued metabolic disorder-related impairment of ischemia-induced revascularisation.METHODS AND RESULTSTo investigate the role of endothelial TXNIP, the TXNIP gene was deleted in endothelial cells using anti-TXNIP siRNA treatment or the Cre-LoxP system. Murine models were fed a HFHPLC diet, known to induce metabolic disorders. Endothelial TXNIP targeting resulted in protection against metabolic disorder-related endothelial oxidative stress and endothelial dysfunction. This protective effect mitigates media cell loss induced by metabolic disorders and hampered metabolic disorder-related vascular dysfunction assessed by aortic reactivity and distensibility. In aortic ring cultures, metabolic disorders impaired vessel sprouting and this alteration was alleviated by deletion of endothelial TXNIP. When subjected to ischemia, mice fed a HFHPLC diet exhibited defective post-ischemic angiogenesis and impaired blood flow recovery in hind limb ischemia. However, reducing endothelial TXNIP rescued metabolic disorder-related impairment of ischemia-induced revascularisation.Collectively, these results show that targeting endothelial TXNIP in metabolic disorders is essential to maintaining endothelial function, vascular function and improving ischemia-induced revascularisation, making TXNIP a potential therapeutic target for therapy of vascular complications related to metabolic disorders.CONCLUSIONCollectively, these results show that targeting endothelial TXNIP in metabolic disorders is essential to maintaining endothelial function, vascular function and improving ischemia-induced revascularisation, making TXNIP a potential therapeutic target for therapy of vascular complications related to metabolic disorders.
Introduction Although thioredoxin-interacting protein (TXNIP) is involved in a variety of biological functions, the contribution of endothelial TXNIP has not been well-defined in regards to endothelial and vascular function or in post-ischemic revascularisation. We postulated that inhibition of endothelial TXNIP with siRNA or in a Cre-LoxP system could be involved in protection from high fat, high protein, low carbohydrate (HFHPLC) diet-induced oxidative stress and endothelial dysfunction, leading to vascular damage and impaired revascularisation in vivo. Methods and results To investigate the role of endothelial TXNIP, the TXNIP gene was deleted in endothelial cells using anti-TXNIP siRNA treatment or the Cre-LoxP system. Murine models were fed a HFHPLC diet, known to induce metabolic disorders. Endothelial TXNIP targeting resulted in protection against metabolic disorder-related endothelial oxidative stress and endothelial dysfunction. This protective effect mitigates media cell loss induced by metabolic disorders and hampered metabolic disorder-related vascular dysfunction assessed by aortic reactivity and distensibility. In aortic ring cultures, metabolic disorders impaired vessel sprouting and this alteration was alleviated by deletion of endothelial TXNIP. When subjected to ischemia, mice fed a HFHPLC diet exhibited defective post-ischemic angiogenesis and impaired blood flow recovery in hind limb ischemia. However, reducing endothelial TXNIP rescued metabolic disorder-related impairment of ischemia-induced revascularisation. Conclusion Collectively, these results show that targeting endothelial TXNIP in metabolic disorders is essential to maintaining endothelial function, vascular function and improving ischemia-induced revascularisation, making TXNIP a potential therapeutic target for therapy of vascular complications related to metabolic disorders.
IntroductionAlthough thioredoxin-interacting protein (TXNIP) is involved in a variety of biological functions, the contribution of endothelial TXNIP has not been well-defined in regards to endothelial and vascular function or in post-ischemic revascularisation. We postulated that inhibition of endothelial TXNIP with siRNA or in a Cre-LoxP system could be involved in protection from high fat, high protein, low carbohydrate (HFHPLC) diet-induced oxidative stress and endothelial dysfunction, leading to vascular damage and impaired revascularisation in vivo.Methods and resultsTo investigate the role of endothelial TXNIP, the TXNIP gene was deleted in endothelial cells using anti-TXNIP siRNA treatment or the Cre-LoxP system. Murine models were fed a HFHPLC diet, known to induce metabolic disorders. Endothelial TXNIP targeting resulted in protection against metabolic disorder-related endothelial oxidative stress and endothelial dysfunction. This protective effect mitigates media cell loss induced by metabolic disorders and hampered metabolic disorder-related vascular dysfunction assessed by aortic reactivity and distensibility. In aortic ring cultures, metabolic disorders impaired vessel sprouting and this alteration was alleviated by deletion of endothelial TXNIP. When subjected to ischemia, mice fed a HFHPLC diet exhibited defective post-ischemic angiogenesis and impaired blood flow recovery in hind limb ischemia. However, reducing endothelial TXNIP rescued metabolic disorder-related impairment of ischemia-induced revascularisation.ConclusionCollectively, these results show that targeting endothelial TXNIP in metabolic disorders is essential to maintaining endothelial function, vascular function and improving ischemia-induced revascularisation, making TXNIP a potential therapeutic target for therapy of vascular complications related to metabolic disorders.
INTRODUCTION:Although thioredoxin-interacting protein (TXNIP) is involved in a variety of biological functions, the contribution of endothelial TXNIP has not been well-defined in regards to endothelial and vascular function or in post-ischemic revascularisation. We postulated that inhibition of endothelial TXNIP with siRNA or in a Cre-LoxP system could be involved in protection from high fat, high protein, low carbohydrate (HFHPLC) diet-induced oxidative stress and endothelial dysfunction, leading to vascular damage and impaired revascularisation in vivo.METHODS AND RESULTS:To investigate the role of endothelial TXNIP, the TXNIP gene was deleted in endothelial cells using anti-TXNIP siRNA treatment or the Cre-LoxP system. Murine models were fed a HFHPLC diet, known to induce metabolic disorders. Endothelial TXNIP targeting resulted in protection against metabolic disorder-related endothelial oxidative stress and endothelial dysfunction. This protective effect mitigates media cell loss induced by metabolic disorders and hampered metabolic disorder-related vascular dysfunction assessed by aortic reactivity and distensibility. In aortic ring cultures, metabolic disorders impaired vessel sprouting and this alteration was alleviated by deletion of endothelial TXNIP. When subjected to ischemia, mice fed a HFHPLC diet exhibited defective post-ischemic angiogenesis and impaired blood flow recovery in hind limb ischemia. However, reducing endothelial TXNIP rescued metabolic disorder-related impairment of ischemia-induced revascularisation.CONCLUSION:Collectively, these results show that targeting endothelial TXNIP in metabolic disorders is essential to maintaining endothelial function, vascular function and improving ischemia-induced revascularisation, making TXNIP a potential therapeutic target for therapy of vascular complications related to metabolic disorders.
Although thioredoxin-interacting protein (TXNIP) is involved in a variety of biological functions, the contribution of endothelial TXNIP has not been well-defined in regards to endothelial and vascular function or in post-ischemic revascularisation. We postulated that inhibition of endothelial TXNIP with siRNA or in a Cre-LoxP system could be involved in protection from high fat, high protein, low carbohydrate (HFHPLC) diet-induced oxidative stress and endothelial dysfunction, leading to vascular damage and impaired revascularisation in vivo. To investigate the role of endothelial TXNIP, the TXNIP gene was deleted in endothelial cells using anti-TXNIP siRNA treatment or the Cre-LoxP system. Murine models were fed a HFHPLC diet, known to induce metabolic disorders. Endothelial TXNIP targeting resulted in protection against metabolic disorder-related endothelial oxidative stress and endothelial dysfunction. This protective effect mitigates media cell loss induced by metabolic disorders and hampered metabolic disorder-related vascular dysfunction assessed by aortic reactivity and distensibility. In aortic ring cultures, metabolic disorders impaired vessel sprouting and this alteration was alleviated by deletion of endothelial TXNIP. When subjected to ischemia, mice fed a HFHPLC diet exhibited defective post-ischemic angiogenesis and impaired blood flow recovery in hind limb ischemia. However, reducing endothelial TXNIP rescued metabolic disorder-related impairment of ischemia-induced revascularisation. Collectively, these results show that targeting endothelial TXNIP in metabolic disorders is essential to maintaining endothelial function, vascular function and improving ischemia-induced revascularisation, making TXNIP a potential therapeutic target for therapy of vascular complications related to metabolic disorders.
Author Henrion, Daniel
Domingues, Alison
Smadja, David M.
Mignon, Virginie
Vessières, Emilie
Marquet de Rouge, Perrine
Dizier, Blandine
Escriou, Virginie
Bigey, Pascal
Boisson-Vidal, Catherine
Chaussain, Catherine
Sadoine, Jérémy
Nivet-Antoine, Valérie
Author_xml – sequence: 1
  givenname: Alison
  surname: Domingues
  fullname: Domingues, Alison
  organization: INSERM 1140, Innovative Therapies in Haemostasis, Faculty of Pharmacy, Université de Paris
– sequence: 2
  givenname: Catherine
  surname: Boisson-Vidal
  fullname: Boisson-Vidal, Catherine
  organization: INSERM 1140, Innovative Therapies in Haemostasis, Faculty of Pharmacy, Université de Paris
– sequence: 3
  givenname: Perrine
  surname: Marquet de Rouge
  fullname: Marquet de Rouge, Perrine
  organization: INSERM 1140, Innovative Therapies in Haemostasis, Faculty of Pharmacy, Université de Paris
– sequence: 4
  givenname: Blandine
  surname: Dizier
  fullname: Dizier, Blandine
  organization: INSERM 1140, Innovative Therapies in Haemostasis, Faculty of Pharmacy, Université de Paris
– sequence: 5
  givenname: Jérémy
  surname: Sadoine
  fullname: Sadoine, Jérémy
  organization: EA 2496, Laboratory of Orofacial Pathologies, Imaging and Biotherapies, Dental School, Université de Paris
– sequence: 6
  givenname: Virginie
  surname: Mignon
  fullname: Mignon, Virginie
  organization: PTICM, CNRS, INSERM 3612, Université de Paris
– sequence: 7
  givenname: Emilie
  surname: Vessières
  fullname: Vessières, Emilie
  organization: CNRS, INSERM 1083, MITOVASC, Université Angers
– sequence: 8
  givenname: Daniel
  surname: Henrion
  fullname: Henrion, Daniel
  organization: CNRS, INSERM 1083, MITOVASC, Université Angers
– sequence: 9
  givenname: Virginie
  surname: Escriou
  fullname: Escriou, Virginie
  organization: CNRS, Unité de Technologies Chimiques et Biologiques pour la santé (UTCBS), UMR 8258, INSERM 1022, Université de Paris
– sequence: 10
  givenname: Pascal
  surname: Bigey
  fullname: Bigey, Pascal
  organization: CNRS, Unité de Technologies Chimiques et Biologiques pour la santé (UTCBS), UMR 8258, INSERM 1022, Université de Paris
– sequence: 11
  givenname: Catherine
  surname: Chaussain
  fullname: Chaussain, Catherine
  organization: EA 2496, Laboratory of Orofacial Pathologies, Imaging and Biotherapies, Dental School, Université de Paris, Odontology Department, AP-HP, Bretonneau Hospital
– sequence: 12
  givenname: David M.
  surname: Smadja
  fullname: Smadja, David M.
  organization: INSERM 1140, Innovative Therapies in Haemostasis, Faculty of Pharmacy, Université de Paris, Service d’Hématologie et Laboratoire de Recherches Biochirugicales (Fondation Carpentier), AH-HP, Georges Pompidou European Hospital
– sequence: 13
  givenname: Valérie
  surname: Nivet-Antoine
  fullname: Nivet-Antoine, Valérie
  email: valerie.nivet-antoine@parisdescartes.fr
  organization: INSERM 1140, Innovative Therapies in Haemostasis, Faculty of Pharmacy, Université de Paris, Clinical Biochemistry Department, AP-HP, Necker Hospital
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31900750$$D View this record in MEDLINE/PubMed
https://inserm.hal.science/inserm-02429278$$DView record in HAL
BookMark eNp9ks1u3CAUha0qVTNJ-wJdVEjdJFJpwX-YZRS1SaRR28VU6g5d4-sZIhumgKPJK_Upy4yTVMoiYoGA7xwul3OSHVlnMcvec_aZMya-BM7KqqaMS8qkYCXdvcoWvBIFFTmTR9mCyVrSOh0dZych3DKWNpryTXZccJkMKrbI_q7ArzEauyZoOxc3OBgYSNwY57FzO2OpsRE96AOz9S6iseRs9fv7zc_zea1jIL13IxkxQusGo0lngvMdeupxgIgdMeMWjB_RRuJ6cgdBTwN40k82GTtLwHZk60KkJugNjsnC4yNlAuyZt9nrHoaA7x7m0-zXt6-ry2u6_HF1c3mxpLoUTaSghRCsgQqLnuk0UjNEVxa8bVvGeJsXDRQlbwC6rm2k4Bp7XUmet00NncyL0-zT7LuBQW29GcHfKwdGXV8slbEB_ahYXuYyF80dT_jZjKde_JkwRDWmN-AwgEU3BZUXRVFzVtd754_P0Fs3eZsek6hGVrxueJWoDw_U1I7YPZXw-GkJyGdAexeCx_4J4Uztk6HmZKiUDHVIhtolUfNMpE089DV6MMPL0mKWhnSPXaP_X_YLqn-qa9F_
CitedBy_id crossref_primary_10_1016_S1875_5364_24_60562_5
crossref_primary_10_1155_2021_6699516
crossref_primary_10_1097_SHK_0000000000001920
crossref_primary_10_1161_CIRCRESAHA_122_321538
crossref_primary_10_1016_j_jare_2023_11_018
crossref_primary_10_3389_fcell_2021_636553
crossref_primary_10_1007_s10456_022_09835_8
crossref_primary_10_1096_fj_202101772R
crossref_primary_10_4239_wjd_v12_i12_1979
crossref_primary_10_2174_2589977515666230214101808
crossref_primary_10_1016_j_jare_2024_02_006
crossref_primary_10_1016_j_esxm_2022_100500
crossref_primary_10_1016_j_mvr_2022_104396
crossref_primary_10_1155_2022_7105181
crossref_primary_10_1155_2021_5529810
crossref_primary_10_1161_ATVBAHA_121_316472
crossref_primary_10_3390_ijms22041693
crossref_primary_10_3389_fphys_2021_707634
crossref_primary_10_1186_s13287_024_03850_w
crossref_primary_10_1016_j_jhazmat_2022_130623
crossref_primary_10_3389_fphys_2021_700585
crossref_primary_10_1038_s41598_021_96220_y
Cites_doi 10.1016/j.stem.2013.10.010
10.1161/ATVBAHA.116.307648
10.1007/s10456-018-9613-x
10.1111/jth.14417
10.1016/j.vph.2017.05.005
10.1371/journal.pmed.0040158
10.1007/s12015-017-9718-4
10.1152/ajpheart.2001.280.6.H2779
10.1177/1479164118793986
10.1016/j.acra.2013.06.003
10.1161/HYPERTENSIONAHA.114.04348
10.1016/j.biocel.2011.09.005
10.1155/2018/6306542
10.1161/RES.0000000000000054
10.1016/j.bbamcr.2007.10.012
10.1016/j.jss.2014.01.020
10.2337/db13-0417
10.1074/jbc.M109.010504
10.1093/gerona/glv071
10.1016/j.freeradbiomed.2010.07.016
10.1161/01.res.0000020401.61826.ea
10.1038/nprot.2011.435
10.1016/j.atherosclerosis.2011.03.038
10.1093/gerona/glt081
10.1016/j.biochi.2010.07.018
10.1126/scisignal.2004235
10.2337/db13-0890
10.1371/journal.pone.0150085
10.1002/dvdy.20643
10.1152/ajpendo.00332.2001
10.1074/jbc.M109.057729
10.1038/s41569-018-0030-z
10.4049/jimmunol.0804221
10.2105/ajph.41.3.279
10.1161/01.RES.0000218193.51136.ad
10.1161/HYPERTENSIONAHA.113.01925
10.1161/CIRCRESAHA.108.188771
10.4049/jimmunol.164.12.6287
10.1097/MCO.0b013e328354a326
10.1016/j.redox.2016.11.002
10.1152/ajpheart.00551.2006
10.1016/j.atherosclerosis.2012.12.015
10.1007/s12015-019-09881-8
10.1073/pnas.0907995106
10.1038/nature04634
10.1038/7434
10.1152/physrev.00006.2013
10.1074/jbc.M400549200
10.1172/JCI44927
10.1160/TH14-09-0748
10.1074/jbc.M112.419101
10.3390/antiox6030047
10.1038/nm740
10.2353/ajpath.2006.060042
10.1002/1873-3468.13156
10.1152/ajpheart.00291.2014
10.1007/978-1-4939-3718-9_8
10.1016/j.numecd.2009.02.011
10.1161/01.res.87.10.840
10.1038/ni.1831
10.1113/jphysiol.2007.143750
10.1161/01.cir.99.24.3188
10.1016/j.nbd.2012.02.008
10.1096/fj.201700856RRR
10.1016/j.jss.2005.06.013
10.1161/HYPERTENSIONAHA.111.181644
ContentType Journal Article
Copyright Springer Nature B.V. 2020
Springer Nature B.V. 2020.
Distributed under a Creative Commons Attribution 4.0 International License
Copyright_xml – notice: Springer Nature B.V. 2020
– notice: Springer Nature B.V. 2020.
– notice: Distributed under a Creative Commons Attribution 4.0 International License
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QO
7X7
7XB
88E
8AO
8FD
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FR3
FYUFA
GHDGH
K9.
M0S
M1P
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
1XC
DOI 10.1007/s10456-019-09704-x
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Biotechnology Research Abstracts
ProQuest Health & Medical Collection (NC LIVE)
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
ProQuest One Community College
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
Hyper Article en Ligne (HAL)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

Technology Research Database

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1573-7209
EndPage 264
ExternalDocumentID oai_HAL_inserm_02429278v1
31900750
10_1007_s10456_019_09704_x
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-5E
-5G
-BR
-EM
-Y2
-~C
.86
.VR
06C
06D
0R~
0VY
1N0
1SB
203
23M
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
3V.
4.4
406
408
409
40D
40E
53G
5GY
5VS
67N
67Z
6NX
7X7
88E
8AO
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACDTI
ACGFS
ACHSB
ACHXU
ACIWK
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACSNA
ACZOJ
ADBBV
ADHHG
ADHIR
ADINQ
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFGCZ
AFKRA
AFLOW
AFQWF
AFRAH
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BDATZ
BENPR
BGNMA
BPHCQ
BSONS
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
EBD
EBLON
EBS
EIOEI
EJD
EMB
EMOBN
EN4
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GXS
H13
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
ITM
IWAJR
IXC
IXE
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KPH
LAK
LLZTM
M1P
M4Y
MA-
N2Q
NB0
NPVJJ
NQJWS
NU0
O9-
O93
O9I
O9J
OAM
OVD
P2P
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOR
QOS
R89
R9I
RNI
ROL
RPX
RRX
RSV
RZC
RZE
RZK
S16
S1Z
S27
S3A
S3B
SAP
SDH
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZN
T13
TEORI
TSG
TSK
TSV
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
YLTOR
Z45
Z7U
Z82
Z87
ZMTXR
ZOVNA
~A9
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7QO
7XB
8FD
8FK
ABRTQ
FR3
K9.
P64
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
1XC
ID FETCH-LOGICAL-c478t-ac77708a5e3f0c0c07207d431bbb001b238a3418aaddb8971cefc5912b86ad923
IEDL.DBID 7X7
ISSN 0969-6970
1573-7209
IngestDate Fri May 09 12:18:21 EDT 2025
Fri Jul 11 05:37:37 EDT 2025
Sat Jul 26 02:26:58 EDT 2025
Thu Apr 03 06:57:25 EDT 2025
Thu Apr 24 22:53:12 EDT 2025
Tue Jul 01 02:35:26 EDT 2025
Fri Feb 21 02:34:41 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Endothelial dysfunction
Oxidative stress
TXNIP
Arterial damage
Metabolic disorders
Post-ischemic revascularisation
Language English
License Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c478t-ac77708a5e3f0c0c07207d431bbb001b238a3418aaddb8971cefc5912b86ad923
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-7731-9202
0000-0001-5686-9301
0000-0002-5493-455X
0000-0001-6651-4926
0000-0003-1094-0285
0000-0002-3463-3936
PMID 31900750
PQID 2389516815
PQPubID 42475
PageCount 16
ParticipantIDs hal_primary_oai_HAL_inserm_02429278v1
proquest_miscellaneous_2333610662
proquest_journals_2389516815
pubmed_primary_31900750
crossref_primary_10_1007_s10456_019_09704_x
crossref_citationtrail_10_1007_s10456_019_09704_x
springer_journals_10_1007_s10456_019_09704_x
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-05-01
PublicationDateYYYYMMDD 2020-05-01
PublicationDate_xml – month: 05
  year: 2020
  text: 2020-05-01
  day: 01
PublicationDecade 2020
PublicationPlace Dordrecht
PublicationPlace_xml – name: Dordrecht
– name: Germany
PublicationTitle Angiogenesis (London)
PublicationTitleAbbrev Angiogenesis
PublicationTitleAlternate Angiogenesis
PublicationYear 2020
Publisher Springer Netherlands
Springer Nature B.V
Springer Verlag
Publisher_xml – name: Springer Netherlands
– name: Springer Nature B.V
– name: Springer Verlag
References Shireman, Quinones (CR41) 2005; 129
Wu, Ren, Zheng (CR47) 2017; 37
Nowak-Sliwinska, Alitalo, Allen (CR56) 2018; 21
Arruda, Schlegel, Bigey, Escriou (CR38) 2016; 1445
Baker, Robinson, Lechertier (CR43) 2011; 7
Forrester, Seth, Hausladen (CR53) 2009; 284
Csiszar, Ungvari, Edwards (CR17) 2002; 90
Incalza, D'Oria, Natalicchio (CR7) 2018; 100
Sun, Deng, Zhou (CR46) 2018; 2018
Jeong, Piao, Kim (CR37) 2009; 183
Kogata, Arai, Pearson (CR62) 2006; 98
Siu, Li, Zhang (CR49) 2017; 11
Albadawi, Oklu, Cormier (CR11) 2014; 190
Ebrahimian, Heymes, You (CR19) 2006; 169
Kim, Jung, Narasimhan (CR25) 2012; 46
Jia, Sowers (CR8) 2014; 64
Smadja (CR65) 2017; 13
Haddad, Dussault, Groleau (CR20) 2011; 217
Shah, Xia, Goldberg (CR27) 2013; 288
Zhou, Yu, Chng (CR33) 2011; 43
Warren, Ziyad, Briot (CR21) 2014; 7
Nebuloni, Kuhn, Müller (CR42) 2013; 20
Cai, Harrison (CR15) 2000; 87
Alva, Zovein, Monvoisin (CR39) 2006; 235
Moon, Thompson, Madamanchi (CR50) 2001; 280
Zhou, Tardivel, Thorens (CR32) 2010; 11
Couffinhal, Silver, Kearney (CR12) 1999; 99
Richter, Freisinger, Lüders (CR6) 2018; 15
Shin, Jeon, Jeong (CR58) 2008; 1783
Kilani, Gourdou Latyszenok, Guy (CR63) 2019; 17
Yoshioka, Chutkow, Lee (CR40) 2012; 122
Parikh, Carlsson, Chutkow (CR34) 2007; 4
Clifton (CR1) 2009; 19
Hattori, Heissig, Wu (CR54) 2002; 8
Houstis, Rosen, Lander (CR22) 2006; 440
Bedarida, Domingues, Baron (CR31) 2018; 32
Gendron, Thorin-Trescases, Villeneuve, Thorin (CR52) 2007; 292
Cha-Molstad, Saxena, Chen, Shalev (CR44) 2009; 284
Hebert-Schuster, Fabre, Nivet-Antoine (CR23) 2012; 15
Garg, Biggs, Carnethon (CR5) 2014; 63
Farrell, Rogers, Liu (CR57) 2010; 49
Bedarida, Baron, Vessieres (CR2) 2014; 307
Collins, Lyon, Xia (CR16) 2009; 104
Junn, Han, Im (CR24) 2000; 164
Oberacker, Bajorat, Ziola (CR30) 2018; 592
Silvestre, Smadja, Lévy (CR14) 2013; 93
Simons, Alitalo, Annex (CR59) 2015; 116
Elshaer, Mohamed, Coucha (CR36) 2017; 6
Burcelin, Crivelli, Dacosta (CR3) 2002; 282
Dunn, Simpson, Prosser (CR35) 2014; 63
Bedarida, Baron, Vibert (CR26) 2016; 71
Nivet-Antoine, Cottart, Lemaréchal (CR29) 2010; 92
Gaubert, Sigaudo-Roussel, Tartas (CR51) 2007; 585
Foo, Heller, Wykrzykowska (CR4) 2009; 106
Bir, Pattillo, Pardue (CR13) 2014; 63
Rossi, Poirault-Chassac, Bieche (CR66) 2019; 15
Gao, Siu, Chalupsky (CR48) 2012; 59
Schulze, Yoshioka, Takahashi (CR28) 2004; 279
Guerin, Loyer, Vilar (CR64) 2015; 113
Baron, Bedarida, Cottart (CR45) 2014; 69
Dawber, Meadors, Moore (CR9) 1951; 41
Ungvari, Tarantini, Kiss (CR10) 2018; 15
Das, Hatsell, Nannuru (CR60) 2016; 11
Nivet-Antoine, Labat, Shamieh El (CR18) 2013; 227
Takahashi, Kalka, Masuda (CR55) 1999; 5
Joseph, Quach, Walkley (CR61) 2013; 13
V Nivet-Antoine (9704_CR29) 2010; 92
DM Smadja (9704_CR65) 2017; 13
V Nivet-Antoine (9704_CR18) 2013; 227
A Shah (9704_CR27) 2013; 288
R Zhou (9704_CR32) 2010; 11
MT Forrester (9704_CR53) 2009; 284
DC Arruda (9704_CR38) 2016; 1445
NM Das (9704_CR60) 2016; 11
P Clifton (9704_CR1) 2009; 19
SK Moon (9704_CR50) 2001; 280
M Baker (9704_CR43) 2011; 7
T Bedarida (9704_CR26) 2016; 71
B Kilani (9704_CR63) 2019; 17
J Sun (9704_CR46) 2018; 2018
KL Siu (9704_CR49) 2017; 11
J Yoshioka (9704_CR40) 2012; 122
D Shin (9704_CR58) 2008; 1783
P Nowak-Sliwinska (9704_CR56) 2018; 21
P Haddad (9704_CR20) 2011; 217
T Oberacker (9704_CR30) 2018; 592
H Parikh (9704_CR34) 2007; 4
H Cha-Molstad (9704_CR44) 2009; 284
CL Guerin (9704_CR64) 2015; 113
J-S Silvestre (9704_CR14) 2013; 93
M Hebert-Schuster (9704_CR23) 2012; 15
ML Gaubert (9704_CR51) 2007; 585
T Couffinhal (9704_CR12) 1999; 99
J Zhou (9704_CR33) 2011; 43
D Wu (9704_CR47) 2017; 37
S Baron (9704_CR45) 2014; 69
R Burcelin (9704_CR3) 2002; 282
PK Garg (9704_CR5) 2014; 63
T Takahashi (9704_CR55) 1999; 5
M-È Gendron (9704_CR52) 2007; 292
E Rossi (9704_CR66) 2019; 15
AR Collins (9704_CR16) 2009; 104
GS Kim (9704_CR25) 2012; 46
T Bedarida (9704_CR31) 2018; 32
N Houstis (9704_CR22) 2006; 440
SL Elshaer (9704_CR36) 2017; 6
L Nebuloni (9704_CR42) 2013; 20
PC Schulze (9704_CR28) 2004; 279
L Richter (9704_CR6) 2018; 15
G Jia (9704_CR8) 2014; 64
E Junn (9704_CR24) 2000; 164
Z Ungvari (9704_CR10) 2018; 15
M Simons (9704_CR59) 2015; 116
H Albadawi (9704_CR11) 2014; 190
K Hattori (9704_CR54) 2002; 8
T Bedarida (9704_CR2) 2014; 307
SY Foo (9704_CR4) 2009; 106
H Cai (9704_CR15) 2000; 87
MA Incalza (9704_CR7) 2018; 100
TR Dawber (9704_CR9) 1951; 41
JA Alva (9704_CR39) 2006; 235
L Gao (9704_CR48) 2012; 59
SC Bir (9704_CR13) 2014; 63
MR Farrell (9704_CR57) 2010; 49
LL Dunn (9704_CR35) 2014; 63
N Kogata (9704_CR62) 2006; 98
A Csiszar (9704_CR17) 2002; 90
C Joseph (9704_CR61) 2013; 13
CM Warren (9704_CR21) 2014; 7
PK Shireman (9704_CR41) 2005; 129
TG Ebrahimian (9704_CR19) 2006; 169
M Jeong (9704_CR37) 2009; 183
References_xml – volume: 13
  start-page: 520
  year: 2013
  end-page: 533
  ident: CR61
  article-title: Deciphering hematopoietic stem cells in their niches: a critical appraisal of genetic models, lineage tracing, and imaging strategies
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2013.10.010
– volume: 37
  start-page: 694
  year: 2017
  end-page: 706
  ident: CR47
  article-title: NLRP3 (nucleotide oligomerization domain–like receptor family, pyrin domain containing 3)–caspase-1 inflammasome degrades contractile proteins
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/ATVBAHA.116.307648
– volume: 21
  start-page: 425
  year: 2018
  end-page: 532
  ident: CR56
  article-title: Consensus guidelines for the use and interpretation of angiogenesis assays
  publication-title: Angiogenesis
  doi: 10.1007/s10456-018-9613-x
– volume: 17
  start-page: 827
  year: 2019
  end-page: 840
  ident: CR63
  article-title: Comparison of endothelial promoter efficiency and specificity in mice reveals a subset of Pdgfb-positive hematopoietic cells
  publication-title: J Thromb Haemost
  doi: 10.1111/jth.14417
– volume: 100
  start-page: 1
  year: 2018
  end-page: 19
  ident: CR7
  article-title: Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases
  publication-title: Vasc Pharmacol
  doi: 10.1016/j.vph.2017.05.005
– volume: 4
  start-page: e158
  year: 2007
  ident: CR34
  article-title: TXNIP regulates peripheral glucose metabolism in humans
  publication-title: PLoS Med
  doi: 10.1371/journal.pmed.0040158
– volume: 13
  start-page: 198
  year: 2017
  end-page: 201
  ident: CR65
  article-title: Bone marrow very small embryonic-like stem cells: new generation of autologous cell therapy soon ready for prime time?
  publication-title: Stem Cell Rev Rep
  doi: 10.1007/s12015-017-9718-4
– volume: 280
  start-page: H2779
  year: 2001
  end-page: H2788
  ident: CR50
  article-title: Aging, oxidative responses, and proliferative capacity in cultured mouse aortic smooth muscle cells
  publication-title: Am J Physiol Heart Circ Physiol
  doi: 10.1152/ajpheart.2001.280.6.H2779
– volume: 15
  start-page: 504
  year: 2018
  end-page: 510
  ident: CR6
  article-title: Impact of diabetes type on treatment and outcome of patients with peripheral artery disease
  publication-title: Diabetes Vasc Dis Res
  doi: 10.1177/1479164118793986
– volume: 20
  start-page: 1247
  year: 2013
  end-page: 1255
  ident: CR42
  article-title: A comparative analysis of water-soluble and blood-pool contrast agents for in vivo vascular imaging with micro-CT
  publication-title: Acad Radiol
  doi: 10.1016/j.acra.2013.06.003
– volume: 64
  start-page: 1192
  year: 2014
  end-page: 1193
  ident: CR8
  article-title: Endothelial dysfunction potentially interacts with impaired glucose metabolism to increase cardiovascular risk
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.114.04348
– volume: 43
  start-page: 1668
  year: 2011
  end-page: 1673
  ident: CR33
  article-title: TXNIP (VDUP-1, TBP-2): a major redox regulator commonly suppressed in cancer by epigenetic mechanisms
  publication-title: Int J Biochem Cell Biol
  doi: 10.1016/j.biocel.2011.09.005
– volume: 2018
  start-page: 6306542
  year: 2018
  end-page: 6306612
  ident: CR46
  article-title: Endothelium as a potential target for treatment of abdominal aortic aneurysm
  publication-title: Oxid Med Cell Longev
  doi: 10.1155/2018/6306542
– volume: 116
  start-page: e99
  year: 2015
  end-page: e132
  ident: CR59
  article-title: State-of-the-art methods for evaluation of angiogenesis and tissue vascularization: a scientific statement from the American Heart Association
  publication-title: Circ Res
  doi: 10.1161/RES.0000000000000054
– volume: 1783
  start-page: 838
  year: 2008
  end-page: 848
  ident: CR58
  article-title: VDUP1 mediates nuclear export of HIF1alpha via CRM1-dependent pathway
  publication-title: Biochim Biophys Acta
  doi: 10.1016/j.bbamcr.2007.10.012
– volume: 190
  start-page: 683
  year: 2014
  end-page: 691
  ident: CR11
  article-title: Hind limb ischemia-reperfusion injury in diet-induced obese mice
  publication-title: J Surg Res
  doi: 10.1016/j.jss.2014.01.020
– volume: 63
  start-page: 675
  year: 2014
  end-page: 687
  ident: CR35
  article-title: A critical role for thioredoxin-interacting protein in diabetes-related impairment of angiogenesis
  publication-title: Diabetes
  doi: 10.2337/db13-0417
– volume: 284
  start-page: 16898
  year: 2009
  end-page: 16905
  ident: CR44
  article-title: Glucose-stimulated expression of Txnip is mediated by carbohydrate response element-binding protein, p300, and histone H4 acetylation in pancreatic beta cells
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M109.010504
– volume: 71
  start-page: 720
  year: 2016
  end-page: 729
  ident: CR26
  article-title: Resveratrol decreases TXNIP mRNA and protein nuclear expressions with an arterial function improvement in old mice
  publication-title: J Gerontol A
  doi: 10.1093/gerona/glv071
– volume: 49
  start-page: 1361
  year: 2010
  end-page: 1367
  ident: CR57
  article-title: Thioredoxin-interacting protein inhibits hypoxia-inducible factor transcriptional activity
  publication-title: Free Radic Biol Med
  doi: 10.1016/j.freeradbiomed.2010.07.016
– volume: 90
  start-page: 1159
  year: 2002
  end-page: 1166
  ident: CR17
  article-title: Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function
  publication-title: Circ Res
  doi: 10.1161/01.res.0000020401.61826.ea
– volume: 7
  start-page: 89
  year: 2011
  end-page: 104
  ident: CR43
  article-title: Use of the mouse aortic ring assay to study angiogenesis
  publication-title: Nat Protoc
  doi: 10.1038/nprot.2011.435
– volume: 217
  start-page: 340
  year: 2011
  end-page: 349
  ident: CR20
  article-title: Nox2-derived reactive oxygen species contribute to hypercholesterolemia-induced inhibition of neovascularization: effects on endothelial progenitor cells and mature endothelial cells
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2011.03.038
– volume: 69
  start-page: 260
  year: 2014
  end-page: 269
  ident: CR45
  article-title: Dual effects of resveratrol on arterial damage induced by insulin resistance in aged mice
  publication-title: J Gerontol A
  doi: 10.1093/gerona/glt081
– volume: 92
  start-page: 1766
  year: 2010
  end-page: 1771
  ident: CR29
  article-title: Trans-resveratrol downregulates Txnip overexpression occurring during liver ischemia-reperfusion
  publication-title: Biochimie
  doi: 10.1016/j.biochi.2010.07.018
– volume: 7
  start-page: ra1
  year: 2014
  ident: CR21
  article-title: A ligand-independent VEGFR2 signaling pathway limits angiogenic responses in diabetes
  publication-title: Sci Signal
  doi: 10.1126/scisignal.2004235
– volume: 63
  start-page: 270
  year: 2014
  end-page: 281
  ident: CR13
  article-title: Nitrite anion therapy protects against chronic ischemic tissue injury in db/db diabetic mice in a NO/VEGF-dependent manner
  publication-title: Diabetes
  doi: 10.2337/db13-0890
– volume: 11
  start-page: e0150085
  year: 2016
  end-page: e0150118
  ident: CR60
  article-title: In vivo quantitative microcomputed tomographic analysis of vasculature and organs in a normal and diseased mouse model
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0150085
– volume: 235
  start-page: 759
  year: 2006
  end-page: 767
  ident: CR39
  article-title: VE-Cadherin-Cre-recombinase transgenic mouse: a tool for lineage analysis and gene deletion in endothelial cells
  publication-title: Dev Dyn
  doi: 10.1002/dvdy.20643
– volume: 282
  start-page: E834
  year: 2002
  end-page: E842
  ident: CR3
  article-title: Heterogeneous metabolic adaptation of C57BL/6J mice to high-fat diet
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.00332.2001
– volume: 284
  start-page: 36160
  year: 2009
  end-page: 36166
  ident: CR53
  article-title: Thioredoxin-interacting protein (Txnip) is a feedback regulator of S-nitrosylation
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M109.057729
– volume: 15
  start-page: 555
  year: 2018
  end-page: 565
  ident: CR10
  article-title: Endothelial dysfunction and angiogenesis impairment in the ageing vasculature
  publication-title: Nat Rev Cardiol
  doi: 10.1038/s41569-018-0030-z
– volume: 183
  start-page: 2495
  year: 2009
  end-page: 2505
  ident: CR37
  article-title: Thioredoxin-interacting protein regulates hematopoietic stem cell quiescence and mobilization under stress conditions
  publication-title: J Immunol
  doi: 10.4049/jimmunol.0804221
– volume: 41
  start-page: 279
  year: 1951
  end-page: 281
  ident: CR9
  article-title: Epidemiological approaches to heart disease: the Framingham Study
  publication-title: Am J Public Health Nations Health
  doi: 10.2105/ajph.41.3.279
– volume: 98
  start-page: 897
  year: 2006
  end-page: 904
  ident: CR62
  article-title: Cardiac ischemia activates vascular endothelial cadherin promoter in both preexisting vascular cells and bone marrow cells involved in neovascularization
  publication-title: Circ Res
  doi: 10.1161/01.RES.0000218193.51136.ad
– volume: 63
  start-page: 413
  year: 2014
  end-page: 419
  ident: CR5
  article-title: Metabolic syndrome and risk of incident peripheral artery disease
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.113.01925
– volume: 104
  start-page: e42
  year: 2009
  end-page: e54
  ident: CR16
  article-title: Age-accelerated atherosclerosis correlates with failure to upregulate antioxidant genes
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.108.188771
– volume: 164
  start-page: 6287
  year: 2000
  end-page: 6295
  ident: CR24
  article-title: Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function
  publication-title: J Immunol
  doi: 10.4049/jimmunol.164.12.6287
– volume: 15
  start-page: 397
  year: 2012
  end-page: 402
  ident: CR23
  article-title: Catalase polymorphisms and metabolic diseases
  publication-title: Curr Opin Clin Nutr Metab Care
  doi: 10.1097/MCO.0b013e328354a326
– volume: 11
  start-page: 118
  year: 2017
  end-page: 125
  ident: CR49
  article-title: NOX isoforms in the development of abdominal aortic aneurysm
  publication-title: Redox Biol
  doi: 10.1016/j.redox.2016.11.002
– volume: 292
  start-page: H451
  year: 2007
  end-page: H458
  ident: CR52
  article-title: Aging associated with mild dyslipidemia reveals that COX-2 preserves dilation despite endothelial dysfunction
  publication-title: Am J Physiol Heart Circ Physiol
  doi: 10.1152/ajpheart.00551.2006
– volume: 227
  start-page: 100
  year: 2013
  end-page: 105
  ident: CR18
  article-title: Relationship between catalase haplotype and arterial aging
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2012.12.015
– volume: 15
  start-page: 590
  year: 2019
  end-page: 600
  ident: CR66
  article-title: Human endothelial colony forming cells express intracellular CD133 that modulates their vasculogenic properties
  publication-title: Stem Cell Rev Rep
  doi: 10.1007/s12015-019-09881-8
– volume: 106
  start-page: 15418
  year: 2009
  end-page: 15423
  ident: CR4
  article-title: Vascular effects of a low-carbohydrate high-protein diet
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0907995106
– volume: 440
  start-page: 944
  year: 2006
  end-page: 948
  ident: CR22
  article-title: Reactive oxygen species have a causal role in multiple forms of insulin resistance
  publication-title: Nature
  doi: 10.1038/nature04634
– volume: 5
  start-page: 434
  year: 1999
  end-page: 438
  ident: CR55
  article-title: Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization
  publication-title: Nat Med
  doi: 10.1038/7434
– volume: 93
  start-page: 1743
  year: 2013
  end-page: 1802
  ident: CR14
  article-title: Postischemic revascularization: from cellular and molecular mechanisms to clinical applications
  publication-title: Physiol Rev
  doi: 10.1152/physrev.00006.2013
– volume: 279
  start-page: 30369
  year: 2004
  end-page: 30374
  ident: CR28
  article-title: Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M400549200
– volume: 122
  start-page: 267
  year: 2012
  end-page: 279
  ident: CR40
  article-title: Deletion of thioredoxin-interacting protein in mice impairs mitochondrial function but protects the myocardium from ischemia-reperfusion injury
  publication-title: J Clin Investig
  doi: 10.1172/JCI44927
– volume: 113
  start-page: 1084
  year: 2015
  end-page: 1094
  ident: CR64
  article-title: Bone-marrow-derived very small embryonic-like stem cells in patients with critical leg ischaemia: evidence of vasculogenic potential
  publication-title: Thromb Haemost
  doi: 10.1160/TH14-09-0748
– volume: 288
  start-page: 6835
  year: 2013
  end-page: 6848
  ident: CR27
  article-title: Thioredoxin-interacting protein mediates high glucose-induced reactive oxygen species generation by mitochondria and the NADPH oxidase, Nox4, in mesangial cells
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M112.419101
– volume: 6
  start-page: E47
  year: 2017
  ident: CR36
  article-title: Deletion of TXNIP mitigates high-fat diet-impaired angiogenesis and prevents inflammation in a mouse model of critical limb ischemia
  publication-title: Antioxidants
  doi: 10.3390/antiox6030047
– volume: 8
  start-page: 841
  year: 2002
  end-page: 849
  ident: CR54
  article-title: Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment
  publication-title: Nat Med
  doi: 10.1038/nm740
– volume: 169
  start-page: 719
  year: 2006
  end-page: 728
  ident: CR19
  article-title: NADPH oxidase-derived overproduction of reactive oxygen species impairs postischemic neovascularization in mice with type 1 diabetes
  publication-title: Am J Pathol
  doi: 10.2353/ajpath.2006.060042
– volume: 592
  start-page: 2297
  year: 2018
  end-page: 2307
  ident: CR30
  article-title: Enhanced expression of thioredoxin-interacting-protein regulates oxidative DNA damage and aging
  publication-title: FEBS Lett
  doi: 10.1002/1873-3468.13156
– volume: 307
  start-page: H649
  year: 2014
  end-page: H657
  ident: CR2
  article-title: High-protein-low-carbohydrate diet: deleterious metabolic and cardiovascular effects depend on age
  publication-title: Am J Physiol Heart Circ Physiol
  doi: 10.1152/ajpheart.00291.2014
– volume: 1445
  start-page: 137
  year: 2016
  end-page: 148
  ident: CR38
  article-title: Lipoplexes strengthened by anionic polymers: easy preparation of highly effective siRNA vectors based on cationic lipids and anionic polymers
  publication-title: Methods Mol Biol
  doi: 10.1007/978-1-4939-3718-9_8
– volume: 19
  start-page: 379
  year: 2009
  end-page: 382
  ident: CR1
  article-title: High protein diets and weight control
  publication-title: Nutr Metab Cardiovasc Dis
  doi: 10.1016/j.numecd.2009.02.011
– volume: 87
  start-page: 840
  year: 2000
  end-page: 844
  ident: CR15
  article-title: Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress
  publication-title: Circ Res
  doi: 10.1161/01.res.87.10.840
– volume: 11
  start-page: 136
  year: 2010
  end-page: 140
  ident: CR32
  article-title: Thioredoxin-interacting protein links oxidative stress to inflammasome activation
  publication-title: Nature Immunol
  doi: 10.1038/ni.1831
– volume: 585
  start-page: 617
  year: 2007
  end-page: 626
  ident: CR51
  article-title: Endothelium-derived hyperpolarizing factor as an in vivo back-up mechanism in the cutaneous microcirculation in old mice
  publication-title: J Physiol
  doi: 10.1113/jphysiol.2007.143750
– volume: 99
  start-page: 3188
  year: 1999
  end-page: 3198
  ident: CR12
  article-title: Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE-/- mice
  publication-title: Circulation
  doi: 10.1161/01.cir.99.24.3188
– volume: 46
  start-page: 440
  year: 2012
  end-page: 449
  ident: CR25
  article-title: Induction of thioredoxin-interacting protein is mediated by oxidative stress, calcium, and glucose after brain injury in mice
  publication-title: Neurobiol Dis
  doi: 10.1016/j.nbd.2012.02.008
– volume: 32
  start-page: 3108
  year: 2018
  end-page: 3118
  ident: CR31
  article-title: Reduced endothelial thioredoxin-interacting protein protects arteries from damage induced by metabolic stress in vivo
  publication-title: FASEB J
  doi: 10.1096/fj.201700856RRR
– volume: 129
  start-page: 242
  year: 2005
  end-page: 250
  ident: CR41
  article-title: Differential necrosis despite similar perfusion in mouse strains after ischemia
  publication-title: J Surg Res
  doi: 10.1016/j.jss.2005.06.013
– volume: 59
  start-page: 158
  year: 2012
  end-page: 166
  ident: CR48
  article-title: Role of uncoupled endothelial nitric oxide synthase in abdominal aortic aneurysm formation
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.111.181644
– volume: 41
  start-page: 279
  year: 1951
  ident: 9704_CR9
  publication-title: Am J Public Health Nations Health
  doi: 10.2105/ajph.41.3.279
– volume: 5
  start-page: 434
  year: 1999
  ident: 9704_CR55
  publication-title: Nat Med
  doi: 10.1038/7434
– volume: 63
  start-page: 675
  year: 2014
  ident: 9704_CR35
  publication-title: Diabetes
  doi: 10.2337/db13-0417
– volume: 15
  start-page: 590
  year: 2019
  ident: 9704_CR66
  publication-title: Stem Cell Rev Rep
  doi: 10.1007/s12015-019-09881-8
– volume: 6
  start-page: E47
  year: 2017
  ident: 9704_CR36
  publication-title: Antioxidants
  doi: 10.3390/antiox6030047
– volume: 59
  start-page: 158
  year: 2012
  ident: 9704_CR48
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.111.181644
– volume: 11
  start-page: 118
  year: 2017
  ident: 9704_CR49
  publication-title: Redox Biol
  doi: 10.1016/j.redox.2016.11.002
– volume: 227
  start-page: 100
  year: 2013
  ident: 9704_CR18
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2012.12.015
– volume: 284
  start-page: 16898
  year: 2009
  ident: 9704_CR44
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M109.010504
– volume: 13
  start-page: 520
  year: 2013
  ident: 9704_CR61
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2013.10.010
– volume: 164
  start-page: 6287
  year: 2000
  ident: 9704_CR24
  publication-title: J Immunol
  doi: 10.4049/jimmunol.164.12.6287
– volume: 13
  start-page: 198
  year: 2017
  ident: 9704_CR65
  publication-title: Stem Cell Rev Rep
  doi: 10.1007/s12015-017-9718-4
– volume: 49
  start-page: 1361
  year: 2010
  ident: 9704_CR57
  publication-title: Free Radic Biol Med
  doi: 10.1016/j.freeradbiomed.2010.07.016
– volume: 46
  start-page: 440
  year: 2012
  ident: 9704_CR25
  publication-title: Neurobiol Dis
  doi: 10.1016/j.nbd.2012.02.008
– volume: 100
  start-page: 1
  year: 2018
  ident: 9704_CR7
  publication-title: Vasc Pharmacol
  doi: 10.1016/j.vph.2017.05.005
– volume: 235
  start-page: 759
  year: 2006
  ident: 9704_CR39
  publication-title: Dev Dyn
  doi: 10.1002/dvdy.20643
– volume: 217
  start-page: 340
  year: 2011
  ident: 9704_CR20
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2011.03.038
– volume: 585
  start-page: 617
  year: 2007
  ident: 9704_CR51
  publication-title: J Physiol
  doi: 10.1113/jphysiol.2007.143750
– volume: 11
  start-page: e0150085
  year: 2016
  ident: 9704_CR60
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0150085
– volume: 99
  start-page: 3188
  year: 1999
  ident: 9704_CR12
  publication-title: Circulation
  doi: 10.1161/01.cir.99.24.3188
– volume: 183
  start-page: 2495
  year: 2009
  ident: 9704_CR37
  publication-title: J Immunol
  doi: 10.4049/jimmunol.0804221
– volume: 20
  start-page: 1247
  year: 2013
  ident: 9704_CR42
  publication-title: Acad Radiol
  doi: 10.1016/j.acra.2013.06.003
– volume: 116
  start-page: e99
  year: 2015
  ident: 9704_CR59
  publication-title: Circ Res
  doi: 10.1161/RES.0000000000000054
– volume: 15
  start-page: 504
  year: 2018
  ident: 9704_CR6
  publication-title: Diabetes Vasc Dis Res
  doi: 10.1177/1479164118793986
– volume: 43
  start-page: 1668
  year: 2011
  ident: 9704_CR33
  publication-title: Int J Biochem Cell Biol
  doi: 10.1016/j.biocel.2011.09.005
– volume: 282
  start-page: E834
  year: 2002
  ident: 9704_CR3
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.00332.2001
– volume: 106
  start-page: 15418
  year: 2009
  ident: 9704_CR4
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0907995106
– volume: 190
  start-page: 683
  year: 2014
  ident: 9704_CR11
  publication-title: J Surg Res
  doi: 10.1016/j.jss.2014.01.020
– volume: 4
  start-page: e158
  year: 2007
  ident: 9704_CR34
  publication-title: PLoS Med
  doi: 10.1371/journal.pmed.0040158
– volume: 92
  start-page: 1766
  year: 2010
  ident: 9704_CR29
  publication-title: Biochimie
  doi: 10.1016/j.biochi.2010.07.018
– volume: 122
  start-page: 267
  year: 2012
  ident: 9704_CR40
  publication-title: J Clin Investig
  doi: 10.1172/JCI44927
– volume: 11
  start-page: 136
  year: 2010
  ident: 9704_CR32
  publication-title: Nature Immunol
  doi: 10.1038/ni.1831
– volume: 307
  start-page: H649
  year: 2014
  ident: 9704_CR2
  publication-title: Am J Physiol Heart Circ Physiol
  doi: 10.1152/ajpheart.00291.2014
– volume: 63
  start-page: 270
  year: 2014
  ident: 9704_CR13
  publication-title: Diabetes
  doi: 10.2337/db13-0890
– volume: 93
  start-page: 1743
  year: 2013
  ident: 9704_CR14
  publication-title: Physiol Rev
  doi: 10.1152/physrev.00006.2013
– volume: 279
  start-page: 30369
  year: 2004
  ident: 9704_CR28
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M400549200
– volume: 19
  start-page: 379
  year: 2009
  ident: 9704_CR1
  publication-title: Nutr Metab Cardiovasc Dis
  doi: 10.1016/j.numecd.2009.02.011
– volume: 64
  start-page: 1192
  year: 2014
  ident: 9704_CR8
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.114.04348
– volume: 280
  start-page: H2779
  year: 2001
  ident: 9704_CR50
  publication-title: Am J Physiol Heart Circ Physiol
  doi: 10.1152/ajpheart.2001.280.6.H2779
– volume: 90
  start-page: 1159
  year: 2002
  ident: 9704_CR17
  publication-title: Circ Res
  doi: 10.1161/01.res.0000020401.61826.ea
– volume: 17
  start-page: 827
  year: 2019
  ident: 9704_CR63
  publication-title: J Thromb Haemost
  doi: 10.1111/jth.14417
– volume: 37
  start-page: 694
  year: 2017
  ident: 9704_CR47
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/ATVBAHA.116.307648
– volume: 21
  start-page: 425
  year: 2018
  ident: 9704_CR56
  publication-title: Angiogenesis
  doi: 10.1007/s10456-018-9613-x
– volume: 104
  start-page: e42
  year: 2009
  ident: 9704_CR16
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.108.188771
– volume: 440
  start-page: 944
  year: 2006
  ident: 9704_CR22
  publication-title: Nature
  doi: 10.1038/nature04634
– volume: 288
  start-page: 6835
  year: 2013
  ident: 9704_CR27
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M112.419101
– volume: 15
  start-page: 555
  year: 2018
  ident: 9704_CR10
  publication-title: Nat Rev Cardiol
  doi: 10.1038/s41569-018-0030-z
– volume: 169
  start-page: 719
  year: 2006
  ident: 9704_CR19
  publication-title: Am J Pathol
  doi: 10.2353/ajpath.2006.060042
– volume: 69
  start-page: 260
  year: 2014
  ident: 9704_CR45
  publication-title: J Gerontol A
  doi: 10.1093/gerona/glt081
– volume: 2018
  start-page: 6306542
  year: 2018
  ident: 9704_CR46
  publication-title: Oxid Med Cell Longev
  doi: 10.1155/2018/6306542
– volume: 1783
  start-page: 838
  year: 2008
  ident: 9704_CR58
  publication-title: Biochim Biophys Acta
  doi: 10.1016/j.bbamcr.2007.10.012
– volume: 8
  start-page: 841
  year: 2002
  ident: 9704_CR54
  publication-title: Nat Med
  doi: 10.1038/nm740
– volume: 592
  start-page: 2297
  year: 2018
  ident: 9704_CR30
  publication-title: FEBS Lett
  doi: 10.1002/1873-3468.13156
– volume: 7
  start-page: ra1
  year: 2014
  ident: 9704_CR21
  publication-title: Sci Signal
  doi: 10.1126/scisignal.2004235
– volume: 284
  start-page: 36160
  year: 2009
  ident: 9704_CR53
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M109.057729
– volume: 7
  start-page: 89
  year: 2011
  ident: 9704_CR43
  publication-title: Nat Protoc
  doi: 10.1038/nprot.2011.435
– volume: 292
  start-page: H451
  year: 2007
  ident: 9704_CR52
  publication-title: Am J Physiol Heart Circ Physiol
  doi: 10.1152/ajpheart.00551.2006
– volume: 63
  start-page: 413
  year: 2014
  ident: 9704_CR5
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.113.01925
– volume: 71
  start-page: 720
  year: 2016
  ident: 9704_CR26
  publication-title: J Gerontol A
  doi: 10.1093/gerona/glv071
– volume: 1445
  start-page: 137
  year: 2016
  ident: 9704_CR38
  publication-title: Methods Mol Biol
  doi: 10.1007/978-1-4939-3718-9_8
– volume: 98
  start-page: 897
  year: 2006
  ident: 9704_CR62
  publication-title: Circ Res
  doi: 10.1161/01.RES.0000218193.51136.ad
– volume: 129
  start-page: 242
  year: 2005
  ident: 9704_CR41
  publication-title: J Surg Res
  doi: 10.1016/j.jss.2005.06.013
– volume: 87
  start-page: 840
  year: 2000
  ident: 9704_CR15
  publication-title: Circ Res
  doi: 10.1161/01.res.87.10.840
– volume: 15
  start-page: 397
  year: 2012
  ident: 9704_CR23
  publication-title: Curr Opin Clin Nutr Metab Care
  doi: 10.1097/MCO.0b013e328354a326
– volume: 113
  start-page: 1084
  year: 2015
  ident: 9704_CR64
  publication-title: Thromb Haemost
  doi: 10.1160/TH14-09-0748
– volume: 32
  start-page: 3108
  year: 2018
  ident: 9704_CR31
  publication-title: FASEB J
  doi: 10.1096/fj.201700856RRR
SSID ssj0009684
Score 2.3835776
Snippet Introduction Although thioredoxin-interacting protein (TXNIP) is involved in a variety of biological functions, the contribution of endothelial TXNIP has not...
Although thioredoxin-interacting protein (TXNIP) is involved in a variety of biological functions, the contribution of endothelial TXNIP has not been...
IntroductionAlthough thioredoxin-interacting protein (TXNIP) is involved in a variety of biological functions, the contribution of endothelial TXNIP has not...
INTRODUCTION:Although thioredoxin-interacting protein (TXNIP) is involved in a variety of biological functions, the contribution of endothelial TXNIP has not...
SourceID hal
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 249
SubjectTerms Angiogenesis
Animal models
Animals
Aorta
Biomedical and Life Sciences
Biomedicine
Blood flow
Blood vessels
Cancer Research
Carbohydrates
Cardiology
Cardiology and cardiovascular system
Carrier Proteins - genetics
Cell Biology
Cells, Cultured
Cellular Biology
Complications
Cytoprotection - genetics
Diet
Endothelial cells
Endothelial Cells - physiology
High carbohydrate diet
High protein diet
Hindlimb - blood supply
Human health and pathology
Impairment
In vivo methods and tests
Ischemia
Ischemia - genetics
Ischemia - metabolism
Ischemia - physiopathology
Ischemia - prevention & control
Life Sciences
Low carbohydrate diet
Low protein diet
Male
Metabolic Diseases - complications
Metabolic Diseases - genetics
Metabolic Diseases - metabolism
Metabolic Diseases - physiopathology
Metabolic disorders
Mice
Mice, Inbred C57BL
Mice, Knockout
Neovascularization, Physiologic - genetics
Nutrient deficiency
Oncology
Ophthalmology
Original Paper
Oxidative stress
Oxidative Stress - physiology
Proteins
siRNA
Subcellular Processes
Therapeutic applications
Thioredoxin
Thioredoxins - genetics
SummonAdditionalLinks – databaseName: SpringerLink Journals (ICM)
  dbid: U2A
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Rb9MwELZgSIgXNDZgYQMZCRAILMVpYjuPFWIqCCYeWqlvke04WqTWmdoMjb-0X7k712lBAyRUKX3o5ZLqznef7e_OhLyCpK1LyDssdxouqYY4KGzK7KhUjbOZ4xu2xZmYzPIv82Iei8LWA9t92JIMkfqXYjdI9jD1RYqPTHMGyPFeAXN3JHLNsvGu1a4I5wzDd8kESMZSmT_r-C0d3T1HMuRtpHlrlzQkn9N98jCiRjremPkRueP8ATkce5gxL3_SNzTwOMMC-QG5_y1ulx-S62ngeYNK6nyNtVYLcDfan7cd9gm9aj3DdhGhUApkQs-G1tO30_nZ5-_vaOzhsKZYg0KXrgeHWbSW1rFjJwuFMK6mWGrZrnCdkXYNHcitFHMm2p1qX9OLbt2zFubSyManKzdIRTrRYzI7_TT9OGHxcAZmc6l6pq2UMlW6cKMmtfCRWSprgCPGIBAzAAU0ZEilIYAaVUpuXWOLkmdGCV0DrHxC9nzn3RGhptamkVpwm5e5dMYUlnPUr0BrkxYJ4YONKhs7l-MBGotq13MZ7VqBXatg1-oqIe-391xs-nb8U_o1mH4riC23J-OvVeshDCwrhDFlJtUPnpCTwTmqONbXFfxT8HihOLzoy-3PMEpx60V7112izGgEQFWILCFPN061fRoEwQDcEvJh8LKd8r-_87P_Ez8mDzJcKghczROy168u3XPAU715EYbPDRyqGf0
  priority: 102
  providerName: Springer Nature
Title Targeting endothelial thioredoxin-interacting protein (TXNIP) protects from metabolic disorder-related impairment of vascular function and post-ischemic revascularisation
URI https://link.springer.com/article/10.1007/s10456-019-09704-x
https://www.ncbi.nlm.nih.gov/pubmed/31900750
https://www.proquest.com/docview/2389516815
https://www.proquest.com/docview/2333610662
https://inserm.hal.science/inserm-02429278
Volume 23
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ti9NAEB68OxC_iN75Eu88VlBRdDFJk2zySar0rG_lkBbqp7C72XCBNum1Oal_yV_pzHbTIodHIYFmOg3M7Mzs7MwzAM_RacsM_Q6PjMSLL9EOJtrnupelpdGhCTbVFqNkOIm-TOOpS7itXFllZxOtoS4aTTnyd-hakG-SBvH7xSWnqVF0uupGaOzBAUGXkVaLqdiB7iZ24jDeM55kwndNM651DkMH3EhTwZDwI77-xzHtXVBZ5PWY89p5qXVDZ_fgrosfWX8j8Ptwy9SHcNSvce88_81eMlvRaVPlh3D7uzs4P4I_Y1vxjSyZqQvqupqh4rH2omoIMXRd1ZyAI2zLFNJY9IaqZq_G09Hn89fMoTmsGHWjsLlpUXVmlWaFw-7ktiXGFIyaLqslZRxZU7KuzJWR9yQNYLIu2KJZtbzCXTXV5bOl6ahcYdEDmJwNxh-H3I1p4DoSaculFkL4qYxNr_Q1fkToiwIDE6UoJFMoOYm-MpVoSlWaiUCbUsdZEKo0kQUGmA9hv25q8xiYKqQqhUwCHWWRMErFOgiIf4pcSz_2IOhklGuHYU6jNGb5Dn2Z5JqjXHMr13ztwZvtbxYbBI8bqV-g6LeEBL497H_LqxoNwjyngCYLRfor8OCkU47crfpVvtNRD55tH-N6pUMYWZvmimh6PQxZkyT04NFGqbb_hubQhnAevO20bMf8_-_85OZ3OYY7ISUJbJXmCey3yyvzFCOpVp3a5XIKB_1PP78O8P5hMDr_gd9Owv5fUXsgpw
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtNAEB6VIkEvCFqghgKLRBEIVtiO7bUPCEVAldA04pBKuW3X67VqKbFD4kL6Shx4RmY2diJU0VtlKT5kPLY0s_OzO_MNwCt02ipBv8MDo_DHVWgHI-1y3Uni3GjfeKtqi2HUOw2-jcPxFvxpe2GorLK1idZQZ5WmPfIP6FqQbxR74afZD05To-h0tR2hsVKLY3P5C1O2xcf-F5Tvoe8ffR197vFmqgDXgYhrrrQQwo1VaDq5q_ESvisy9KNpShFEii9SaNpjhSs_jRPhaZPrMPH8NI5UlhDQAZr82_iAS8meGIsNyG9kJxzjPeFRItymSadp1cNQBRN3KlASbsCX_zjCW-dUhnk1xr1yPmvd3tF9uNfEq6y7UrAHsGXKXdjrlpirTy_Za2YrSO3W_C7cOWkO6vfg98hWmCNLZsqMurwmqOisPi8qQihdFiUnoArbooU0Fi2iKNmb0XjY__6WNegRC0bdL2xqalTVSaFZ1mCFctuCYzJGTZ7FnHY4WZWztqyWkbcmjWOqzNisWtS8wCye-gDY3LRUTSHTQzi9EQE-gu2yKs0-sDRTaS5U5OkgCYRJ01B7HvGPkWvuhg54rYykbjDTaXTHRG7QnkmuEuUqrVzl0oF362dmK8SQa6kPUfRrQgL77nUHsijRAE0lBVCJL-KfngMHrXLIxsos5GZNOPBy_TfaBzr0UaWpLoim08EQOYp8Bx6vlGr9NjS_NmR04H2rZRvm___mJ9d_ywu42xudDOSgPzx-Cjs-bVDYCtED2K7nF-YZRnF1-twuHQZnN71W_wJ4kFld
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtNAEB6VVKq4IGj5MRRYJIpA1Krt2F77gFCgjRJaogilUm5mvV6rlhI7JC6kr8Qj8HTMbNaJUEVvVSTn4PHY0szOz-7MNwCv0WmLGP2O7SuBF0egHQylY8t2HOVKespdVVsMwt65_2UcjLfgT9MLQ2WVjU3UhjqrJO2RH6FrQb5h5AZHuSmLGB53P85-2DRBik5am3EaKxU5VVe_MH1bfOgfo6wPPK97Mvrcs82EAVv6PKptITnnTiQC1c4diT_uOTxDn5qmFE2k-FKBZj4SaAXSKOauVLkMYtdLo1BkMYEeoPnf5pQVtWD708lg-G0D-Rvqecf4H9thzB3TsmMa9zBwwTSeypW449vLf9zinQsqyrwe8V47rdVOsHsf7pnolXVW6vYAtlS5C3udEjP36RV7w3Q9qd6o34Wdr-bYfg9-j3S9ObJkqsyo52uCas_qi6IivNJlUdoEW6EbtpBGY0cUJXs7Gg_6w3fMYEksGPXCsKmqUXEnhWSZQQ61dUOOyhi1fBZz2u9kVc6aIltGvpv0j4kyY7NqUdsF5vTUFcDmqqEyZU0P4fxWRPgIWmVVqifA0kykORehK_3Y5ypNA-m6xD9CrrkTWOA2MkqkQVCnQR6TZIP9THJNUK6JlmuytOD9-pnZCj_kRuoDFP2akKC_e52zpCjRHE0TCqdij0c_XQv2G-VIjM1ZJJsVYsGr9W20FnQEJEpVXRJNu40Bcxh6FjxeKdX6bWiMdQBpwWGjZRvm___mpzd_y0vYwXWanPUHp8_grke7FbpcdB9a9fxSPceQrk5fmLXD4PttL9e_d-he-A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Targeting+endothelial+thioredoxin-interacting+protein+%28TXNIP%29+protects+from+metabolic+disorder-related+impairment+of+vascular+function+and+post-ischemic+revascularisation&rft.jtitle=Angiogenesis+%28London%29&rft.au=Domingues%2C+Alison&rft.au=Boisson-Vidal%2C+Catherine&rft.au=Marquet+de+Rouge%2C+Perrine&rft.au=Dizier%2C+Blandine&rft.date=2020-05-01&rft.issn=0969-6970&rft.eissn=1573-7209&rft.volume=23&rft.issue=2&rft.spage=249&rft.epage=264&rft_id=info:doi/10.1007%2Fs10456-019-09704-x&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s10456_019_09704_x
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0969-6970&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0969-6970&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0969-6970&client=summon